Iovance Biotherapeautics
IOVA----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Iovance Biotherapeautics(IOVA) predict that the Revenue is 71.43 M (+44.82%), Miss estimate;the EBIT is -81.04 M (+33.14%), Miss estimate;the EPS is -0.19 (+47.22%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.07B44.82%
0.08B53.40%
-0.00B8.58%
EBITMiss expectations
-0.08B33.14%
-0.06B46.72%
-0.02B13.58%
EPSMiss expectations
-0.1947.22%
-0.154357.13%
-0.03579.91%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf